# Phase 4 Arthritis, Rheumatoid trials recruiting: 27 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials in phase 4 for Arthritis, Rheumatoid that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 Arthritis, Rheumatoid trials: 27 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/arthritis-rheumatoid

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 27
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 3, 2026 | NCT07802678 | Discontinuation of Disease-modifying Anti-rheumatic Drugs (DMARDs) in Rheumatoid Arthritis Patients Also Using TNF Inhibitors | Sint Maartenskliniek | Phase 4 | Recruiting | Rheumatoid Arthritis (RA) | 202 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802678) |
| July 22, 2026 | NCT07721142 | Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis | Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine | Phase 4 | Recruiting | Rheumatoid Arthritis (RA) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07721142) |
| June 9, 2026 | NCT07636057 | Comparison of Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis | Sheikh Zayed Federal Postgraduate Medical Institute | Phase 4 | Not yet recruiting | Rheumatoid Arthritis (RA) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07636057) |
| May 28, 2026 | NCT07611747 | Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) | Instituto de Investigación Marqués de Valdecilla | Phase 4 | Recruiting | Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Systemic Lupus Erythematosus (SLE), Carotid Artery Diseases... | 1,944 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07611747) |
| May 12, 2026 | NCT07582185 | Tdose Binding and Tocilizumab | Centre Hospitalier Universitaire de Nice | Phase 4 | Not yet recruiting | Rheumatoid Arthritis | 122 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07582185) |
| April 28, 2026 | NCT07554820 | Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With... | Shaikh Zayed Hospital, Lahore | Phase 4 | Recruiting | Rheumatoid Arthritis, Major Adverse Cardiac Events | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554820) |
| March 5, 2026 | NCT07452445 | Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR Rheumatoid Arthritis | Tongji Hospital | Phase 4 | Not yet recruiting | Rheumatoid Arthritis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07452445) |
| January 22, 2026 | NCT07357649 | Baricitinib Effects on Procoagulant State in Rheumatoid Arthritis | Tanta University | Phase 4 | Not yet recruiting | Rheumatoid Arthritis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07357649) |
| November 24, 2025 | NCT07245732 | Oral Versus Intramuscular Steroid Use to Control Rheumatoid Arthritis Flares | Sunnybrook Health Sciences Centre | Phase 4 | Recruiting | Rheumatoid Arthritis (RA) | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07245732) |
| November 12, 2025 | NCT07227428 | Comparison of Glucocorticoid Tapering Schedules in Rheumatoid Arthritis | Seoul National University Hospital | Phase 4 | Not yet recruiting | Rheumatoid Arthritis (RA) | 206 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07227428) |
| September 8, 2025 | NCT07160231 | REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases | Sint Maartenskliniek | Phase 4 | Recruiting | Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondyloarthritis (AxSpA) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07160231) |
| July 28, 2025 | NCT07087912 | Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases | University of Sao Paulo General Hospital | Phase 4 | Recruiting | Rheumatoid Arthritis (RA), Juvenile Idiopathic Arthritis (JIA), Systemic Lupus Erythematosus (SLE), Juvenile Systemic... | 477 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07087912) |
| June 6, 2025 | NCT07008196 | Telitacicept for the Treatment of Refractory RA | Chinese SLE Treatment And Research Group | Phase 4 | Not yet recruiting | Rheumatoid Arthritis (RA) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07008196) |
| April 25, 2025 | NCT06945666 | A Study of Iguratimod in Combination With Tofacitinib in RA Patients | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Rheumatoid Arthritis (RA | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06945666) |
| April 6, 2025 | NCT06913907 | Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study) | Keio University | Phase 4 | Recruiting | Rheumatoid Arthritis (RA) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06913907) |
| April 2, 2025 | NCT06906549 | Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis | University Hospital, Strasbourg, France | Phase 4 | Recruiting | Rheumatoid Arthritis (RA), Rituximab (RTx) | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06906549) |
| December 9, 2024 | NCT06724952 | Effect of Silymarin in Rheumatoid Arthritis Patients Treated With Methotrexate | Tanta University | Phase 4 | Not yet recruiting | Rheumatoid Arthritis (RA) | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06724952) |
| November 13, 2024 | NCT06687551 | JAK Inhibitor Dose TAPering Strategy Study | University Hospital, Toulouse | Phase 4 | Recruiting | Rheumatoid Arthritis (RA | 308 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06687551) |
| October 18, 2024 | NCT06649136 | MethMax Trial: MAXimising the METHotrexate Therapy Potential in Patients With Active Rheumatoid Arthritis | Medical University of Vienna | Phase 4 | Recruiting | Rheumatoid Arthritis | 182 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06649136) |
| July 30, 2024 | NCT06528431 | Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study | Centre Hospitalier Universitaire de Saint Etienne | Phase 4 | Recruiting | Arthritis, Rheumatoid | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06528431) |
| August 21, 2023 | NCT06003283 | Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid... | Universitaire Ziekenhuizen KU Leuven | Phase 4 | Recruiting | Rheumatoid Arthritis | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06003283) |
| July 21, 2023 | NCT05955066 | Effect of JAK Inhibitor on Erosion Healing in RA | Chinese University of Hong Kong | Phase 4 | Recruiting | Rheumatoid Arthritis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05955066) |
| November 23, 2022 | NCT05626348 | The Clinical Efficacy of Immunomodulators in RA Patients | Qilu Hospital of Shandong University | Phase 4 | Recruiting | Arthritis, Rheumatoid | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05626348) |
| September 15, 2022 | NCT05540938 | Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis | China-Japan Friendship Hospital | Phase 4 | Recruiting | Rheumatoid Arthritis | 340 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05540938) |
| August 2, 2021 | NCT04985435 | Better After CHoosing. Randomly Allocated or Patient Preference Based Treatment With Filgotinib or TNFi in RA (BACH) | Sponsor not shown (see the record) | Phase 4 | Recruiting | Rheumatoid Arthritis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04985435) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Tanta University | 2 |
| Sint Maartenskliniek | 2 |
| University Hospital, Strasbourg, France | 2 |
| Universitaire Ziekenhuizen KU Leuven | 1 |
| University Hospital, Toulouse | 1 |
| Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine | 1 |
| Instituto de Investigación Marqués de Valdecilla | 1 |
| Chinese SLE Treatment And Research Group | 1 |
| Sheikh Zayed Federal Postgraduate Medical Institute | 1 |
| Shaikh Zayed Hospital, Lahore | 1 |
| Seoul National University Hospital | 1 |
| Tongji Hospital | 1 |
| Sunnybrook Health Sciences Centre | 1 |
| Qilu Hospital of Shandong University | 1 |
| China-Japan Friendship Hospital | 1 |
| Keio University | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Medical University of Vienna | 1 |
| Chinese University of Hong Kong | 1 |
| University of Sao Paulo General Hospital | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |

## By country

| Country | Trials |
| --- | --- |
| France | 5 |
| China | 5 |
| Netherlands | 3 |
| Egypt | 2 |
| Canada | 2 |
| Belgium | 1 |
| Spain | 1 |
| Pakistan | 1 |
| Japan | 1 |
| Austria | 1 |
| Hong Kong | 1 |
| Brazil | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Hardware and fastener manufacturers in the United States](https://specstream.ai/data/businesses/hardware-and-fastener-manufacturers/united-states)
- [B2B outdoor advertising companies in the United States](https://specstream.ai/data/businesses/b2b-outdoor-advertising-companies/united-states)
- [Printing equipment suppliers in the United States](https://specstream.ai/data/businesses/printing-equipment-suppliers/united-states)
- [Flooring contractors in the United States](https://specstream.ai/data/businesses/flooring-contractors/united-states)
- [Appraisers in the United States](https://specstream.ai/data/businesses/appraisers/united-states)
- [Payroll companies in the United States](https://specstream.ai/data/businesses/payroll-companies/united-states)
